Biotechnology Companies By Gross Profit

Gross Profit
Gross ProfitEfficiencyMarket RiskExp Return
1ABBV AbbVie Inc
41.53 B
(0.04)
 2.09 
(0.09)
2GILD Gilead Sciences
21.62 B
 0.19 
 1.42 
 0.26 
3AMGN Amgen Inc
19.92 B
(0.13)
 1.69 
(0.22)
4BNTX BioNTech SE
16.07 B
 0.14 
 3.78 
 0.54 
5GMAB Genmab AS
14.6 B
(0.24)
 1.53 
(0.37)
6MRNA Moderna
10.55 B
(0.22)
 3.54 
(0.77)
7BIIB Biogen Inc
7.9 B
(0.28)
 1.33 
(0.38)
8ICCC ImmuCell
7.65 B
 0.00 
 1.85 
 0.00 
9REGN Regeneron Pharmaceuticals
7.02 B
(0.40)
 1.73 
(0.69)
10HLN Haleon plc
6.74 B
(0.08)
 0.97 
(0.08)
11VRTX Vertex Pharmaceuticals
5.32 B
(0.01)
 1.68 
(0.01)
12GRFS Grifols SA ADR
2.23 B
(0.12)
 3.32 
(0.41)
13UTHR United Therapeutics
1.78 B
 0.06 
 1.71 
 0.09 
14BMRN Biomarin Pharmaceutical
1.61 B
(0.19)
 2.60 
(0.48)
15INCY Incyte
1.59 B
 0.09 
 2.52 
 0.22 
16EXEL Exelixis
1.55 B
 0.24 
 2.40 
 0.58 
17EXAS EXACT Sciences
1.51 B
 0.04 
 4.26 
 0.15 
18VIR Vir Biotechnology
1.03 B
 0.03 
 4.31 
 0.12 
19NBIX Neurocrine Biosciences
B
 0.02 
 1.68 
 0.03 
20ALKS Alkermes Plc
893.69 M
 0.03 
 2.37 
 0.08 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments. Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.